Perspective Therapeutics, Inc. - CATX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Sep 04, 2026 SCHEDULE 13D/A 10.0% View
Aug 13, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 5.2% 5,888,184 View
Aug 13, 2026 SCHEDULE 13G/A Millennium Management LLC 5.5% 6,316,545 View
Aug 13, 2026 SCHEDULE 13G/A Millennium Group Management LLC 5.5% 6,316,545 View
Aug 13, 2026 SCHEDULE 13G/A Israel A. Englander 5.5% 6,316,545 View
Aug 07, 2026 SCHEDULE 13G STATE STREET CORPORATION 5.3% 6,051,771 View
Jul 20, 2026 SCHEDULE 13G Millennium Management LLC 5.3% 6,036,999 View
Jul 20, 2026 SCHEDULE 13G Millennium Group Management LLC 5.3% 6,036,999 View
Jul 20, 2026 SCHEDULE 13G Israel A. Englander 5.3% 6,036,999 View
Jun 30, 2026 SCHEDULE 13G Millennium Management LLC 4.3% 4,893,883 View
Jun 30, 2026 SCHEDULE 13G Millennium Group Management LLC 4.3% 4,893,883 View
Jun 30, 2026 SCHEDULE 13G Israel A. Englander 4.3% 4,893,883 View
Apr 27, 2026 SCHEDULE 13G/A BlackRock, Inc. 4.6% 5,251,363 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.